(919) 224-8800 Contact Our Team

Free eBook:

Boosting Enrollment in Oncology Trials

The National Cancer Institute (NCI) estimates that only approximately 3% of US adult cancer patients participate in clinical trials. The low participation rate is a major bottleneck in developing new cancer treatments. Clearly a key factor in progress toward better treatment and prognosis in adult oncology lies in improving participation rates.

Learn more about improving participation rates in adult oncology trials through the use of:

  • Adaptive and simplified trial design
  • Molecular profiling
  • Patient-centric enrollment
  • Communication and education

Download the eBook now: